Timothy Miller
Family Medicine · Coldwater, MINPI 1073882189
Payments from drug & device makers
Across 533 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- Lilly USA, LLC$662
- AstraZeneca$658
- Pfizer$627
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$468
- plus $4K from 33 others
What the payments were for
- Food & beverage$8,447100%
- Education$320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 98 | $1,406 |
| Novo Nordisk | 89 | $1,156 |
| Lilly USA, LLC | 45 | $662 |
| AstraZeneca | 30 | $658 |
| Pfizer | 46 | $627 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $468 |
| Boehringer Ingelheim | 24 | $454 |
| GSK | 28 | $274 |
| Vanda Pharmaceuticals Inc. | 10 | $269 |
| Bayer | 13 | $221 |
| Axsome Therapeutics, Inc. | 8 | $192 |
| Daiichi Sankyo Inc. | 9 | $168 |
| Amgen | 11 | $163 |
| Otsuka America Pharmaceutical, Inc. | 6 | $150 |
| Johnson & Johnson | 8 | $126 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $120 |
| Indivior Inc. | 4 | $119 |
| Dexcom, Inc. | 6 | $115 |
| Novartis | 7 | $112 |
| Biohaven Pharmaceuticals, Inc. | 6 | $104 |
| Lundbeck LLC | 5 | $103 |
| Amarin Pharma, Inc. | 6 | $101 |
| Exact Sciences | 6 | $97 |
| Corcept Therapeutics | 4 | $96 |
| Alkermes, Inc. | 4 | $88 |
| Inspire Medical Systems, Inc. | 3 | $57 |
| Verona Pharma, Inc. | 3 | $57 |
| Endologix LLC | 1 | $46 |
| UCB, Inc. | 2 | $42 |
| GRT US Holding, Inc. | 2 | $37 |
| Mylan Specialty L.p. | 2 | $36 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Abbott | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Electromed, Inc. | 1 | $19 |
| Neurelis, Inc. | 1 | $17 |
| Bausch Health US, LLC | 1 | $17 |
| Insulet Corporation | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,479 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 93 | $89,220 |
| JardianceEmpagliflozin | 71 | $86,959 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 114 | $81,626 |
| FarxigaDapagliflozin Propanediol | 72 | $59,061 |
| OzempicSemaglutide | 56 | $51,204 |
| XareltoRivaroxaban | 49 | $45,470 |
| EliquisApixaban | 47 | $37,189 |
| VraylarCariprazine Hcl | 22 | $33,136 |
| MounjaroTirzepatide | 17 | $27,092 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $20,215 |
| TrintellixVortioxetine Hydrobromide | 15 | $16,189 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 33 | $12,080 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $10,505 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $8,373 |
| Repatha SureclickEvolocumab | 13 | $6,972 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $662 | $116,312110 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $274 | $100,504146 claims |
| Boehringer IngelheimJardiance | $454 | $86,95971 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $658 | $79,27797 claims |
| Novo NordiskOzempic | $1,156 | $51,20456 claims |
| Johnson & JohnsonXarelto | $126 | $45,47049 claims |
| PfizerEliquis | $627 | $37,18947 claims |
| AbbVieVraylar | $1,406 | $33,13622 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $13 | $16,18915 claims |
| Indivior Inc.Suboxone | $119 | $3,64213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Coldwater
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.